Most of us have used Google to find out more about existing medications, but the tech giant also has a life sciences division, which has now entered into a $715 million partnership with big pharma biggie GlaxoSmithKline to form a new company focused on fighting disease through technological innovations. [More]
In Canada, you can buy a tube of brand-name prescription cold sore cream Zovirax for around $50. Its generic equivalent (acyclovir) is half that price. And even here in the states you can find generics acyclovir pills and ointments for a reasonable price, so why does what is effectively the same product sell for more than $2,500 in the U.S.? [More]
In March 2014, drug giant GlaxoSmithKline issued a voluntary recall of the popular alli weight-loss pill over concerns about possible package tampering. Nearly a year later, the over-the-counter drug is finally coming back to stores. [More]
Drug biggie GlaxoSmithKline has been slapped with another huge settlement for its questionable marketing tactics. This time, the pharma company has agreed to pay $105 million to resolve claims made by attorneys general from 45 states regarding the selling of asthma drug Advair and antidepressants Paxil and Wellbutrin. [More]
Big pharma biggie GlaxoSmithKline (GSK) has issued a recall all on all of its alli weight loss products in the U.S., including Puerto Rico, over concerns that packages may have been tampered with, resulting in some bottles containing something other than actual alli capsules. [More]
Earlier today, CVS surprised an awful lot of people by saying it would give up $2 billion a year in cigarette sales because it’s “the right thing for us to do for our customers and our company to help people on their path to better health.” Meanwhile, Walgreens, the nation’s largest drugstore chain, apparently wants the world to know that it will keep on selling tobacco. [More]
Giant drug manufacturer GlaxoSmithKline announced today that it intends to stop paying doctors to prescribe more of the company’s drugs, a move that could possibly entice other large pharma companies to do the same. [More]
Want to know if your doctor is receiving free lunches and other perks from Pfizer, GSK or some other huge player in the pharmaceuticals or medical device business? Starting in Sept. 2014, that information will be made available to consumers courtesy of the federal government. [More]
Yesterday, pharma biggie GlaxoSmithKline settled for $3 billion with the Justice Dept. over a wide range of fraud-related allegations. Among all the documents involved in the case are claims by the DOJ that GSK paid TV/Radio personality Dr. Drew Pinsky a pile of cash to talk up off-label uses of the company’s antidepressant Wellbutrin, including a purported tie to causing multiple orgasms in females.
A class action lawsuit has been filed accusing GlaxoSmithKline of lying to the Patent office and dickering with fake patent litigation against generic drug makers to fraudulently stymie generic versions of Wellbutrin from hitting the market. The lawsuit applies to people who directly bought Wellbutrin from GSK in 100 or 150mg hits between Jan 24, 2002 and June 30, 2006. Obviously, the long GSK could keep a generic version of their drug off the market, the more money they could make. People interested in joining could probably contact the firm of Roda and Nast, lead plaintiff team, for more information.
GlaxoSmithKline is buying a U.S. biotechnology company that is researching resveratrol, the chemical compound found in red wine that may retard the aging process. The CEO of the company says that “drugs that mimic resveratrol, by activating enzymes called sirtuins, could ‘treat in a safe, natural new way, many of the major killers of western society.'” We can’t wait to see the commercials that GSK puts out for this one.
You may recall Paxil as the inspiration for several Law & Order episodes. In 2004, NY Attorney General began proceedings against Paxil makers GlaxoSmithKline after the company suppressed five internal studies between 1998 and 2002 revealing links between the drug and incidences of suicide among its users, especially children and young adults.